Sign inJoin waitlistJoin the waitlist

HC

Herta Chao

Deputy Director at the VA Comprehensive Cancer Center, Section of Hematology/Oncology, VA Connecticut Healthcare System · Yale-New Haven Hospital

Credentials: · · ·

History

Section of Hematology/Oncology · Yale-New Haven Hospital
Present
Yale-New Haven Hospital
Present

Hematology and Medical Oncology
Yale-New Haven Hospital
1999–2002
Dana-Farber Cancer Institute
1996–1999
University of Freiburg
GEORG AUGUST-UNIV, GOTTINGEN
1990–1994

Research

Activation of the pre-supplementary motor area but not inferior prefrontal cortex in association with short stop signal reaction time--an intra-subject analysis
BMC Neuroscience · 2009 · First of 4 authors · 123 citations
Resting-State Functional Connectivity of the Locus Coeruleus in Humans: In Comparison with the Ventral Tegmental Area/Substantia Nigra Pars Compacta and the Effects of Age
Cerebral Cortex · 2016 · 104 citations
Epidemiologic characteristics and multiple risk factors of stomach cancer in Taiwan
Anticancer Research · 1990 · 92 citations

MR
Michal Rose
10 papers
CD
Christopher van Dyck
5 papers
John Krystal
4 papers
TA
Tim Ahles
4 papers
Edward Uchio
3 papers
JC
John Concato
3 papers
Anne Chang
2 papers
Cari Levy
2 papers
Carolyn Presley
2 papers
Cary Gross
2 papers
EW
Ellice Wong
2 papers
James DeCaprio
2 papers

Grants

Effects of ADT on Motivation and Emotion Function in Prostate Cancer Patients: Longitudinal Imaging and Prediction
Department of Veterans Affairs · I01
Contact PI · Va Connecticut Healthcare System
2017–2028
Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients
National Cancer Institute · R01
Contact PI · $1.9M · Yale University
2018–2026
Imaging the Effects of Androgen Deprivation Therapy on Cognitive Functions in Pat
National Cancer Institute · R03
Contact PI · $130.4K · Yale University
2009–2012

Clinical trials

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Site PI · Recruiting · Phase 3
Canadian Cancer Trials Group
2025–2031
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2039
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2020–2027
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 2, Phase 3
SWOG Cancer Research Network
2019–2029